Related Experiment Videos
Clinical safety and efficacy of ofloxacin
1Istituto di Clinica delle Malattie Infettive, Università di Pavia, IRCCS Policlinico S. Matteo, Italy.
Abstract:
In this study we report about the efficacy and tolerability of ofloxacin in the treatment of 15 patients with severe and moderately severe infections including osteomyelitis (5), soft tissue infections (5), salmonellosis in AIDS patients (2), acute or chronic pulmonary infections (2) and mediastinitis (1). The following organisms were isolated in culture specimens: Staphylococcus aureus (4), Pseudomonas aeruginosa (4), Staphylococcus epidermidis (3), Serratia marcescens (1), Escherichia coli (1), Aeromonas hydrophila (1), Klebsiella oxytoca (1), Klebsiella pneumoniae (1), Salmonella cholerae-suis (1), Salmonella sp. (1), Enterobacter cloacae (1). All isolates were sensitive to the drug. Of 5 cases with osteomyelitis, 2 were cured and 3 improved clinically (with bacteriological eradication of the pathogens). The best results were obtained in patients with soft tissue infections: 4 patients were cured and 1 improved. Two patients with salmonella bacteremia and AIDS experienced a recurrence 1 month and 2 months respectively after stopping therapy. The patient with mediastinitis was successfully treated. Improvement was recorded for 2 patients with bronchiectasis and exacerbation of chronic bronchitis. The drug was well tolerated, only one episode of mild nausea and vomiting was reported and did not require discontinuation of the therapy. The study indicates that ofloxacin is a safe and effective agent in the treatment of various infections.
Insights
Ofloxacin demonstrated efficacy and tolerability in treating severe infections like osteomyelitis and soft tissue infections. This fluoroquinolone antibiotic proved safe and effective across various bacterial pathogens, with minimal side effects reported.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Severe bacterial infections pose significant treatment challenges.
- Fluoroquinolones, such as ofloxacin, are broad-spectrum antibiotics.
- Assessing the efficacy and tolerability of new antibiotic regimens is crucial.
Purpose of the Study:
- To evaluate the efficacy and tolerability of ofloxacin.
- To assess ofloxacin's effectiveness in treating severe and moderately severe infections.
- To identify specific infections and pathogens responsive to ofloxacin treatment.
Main Methods:
- A clinical study involving 15 patients with severe infections.
- Inclusion criteria: osteomyelitis, soft tissue infections, salmonellosis in AIDS patients, pulmonary infections, and mediastinitis.
- Microbiological analysis of isolates to determine sensitivity to ofloxacin.
Main Results:
- Ofloxacin showed positive outcomes in osteomyelitis (2 cured, 3 improved) and soft tissue infections (4 cured, 1 improved).
- Successful treatment was observed in mediastinitis and pulmonary infections.
- All isolated pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa, were sensitive to ofloxacin.
Conclusions:
- Ofloxacin is a safe and effective treatment option for a range of severe bacterial infections.
- The drug exhibited good tolerability with only mild, transient side effects.
- Further research may explore ofloxacin's role in specific patient populations, like those with AIDS.